(Total Views: 107)
Posted On: 03/23/2021 9:01:33 AM
Post# of 25168
$CURR News March 23, 2021
CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline https://finance.yahoo.com/news/cure-pharmaceu...00116.html
CURE Pharmaceutical Augments Its Existing U.S. DEA License in Order to Initiate Development of Its Psychedelics-Based Pharmaceutical Clinical Pipeline https://finance.yahoo.com/news/cure-pharmaceu...00116.html
(0)
(0)Scroll down for more posts ▼
